Yang, Tsung-HanTsung-HanYangWang, Chen-YuChen-YuWangSHAU-HUAI FUDING-CHENG CHANChen, Ho-MinHo-MinChenJOU-WEI LINHuang, Chun-FengChun-FengHuangYang, Jen-JiaJen-JiaYangWu, Chih-HsingChih-HsingWuHwang, Jawl-ShanJawl-ShanHwangRONG-SEN YANG2023-11-152023-11-1520230929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/637126Osteoporosis is a common metabolic bone disease that benefits from many newly developed anti-osteoporosis medications (AOMs). Reimbursement policies need to allocate medical budgets properly based on evidence-based data. This study aimed to investigate the 11-year secular trend, focusing on older age and males in this adjustment wave of the National Health Insurance reimbursement.enAnti-Osteoporosis medications; Osteoporosis; Secular trend; Subsequent fractures[SDGs]SDG1[SDGs]SDG3[SDGs]SDG5Eleven years secular trend of the initiation of anti-osteoporosis medications and subsequent fractures in Taiwan: From 2008 to 2018journal article10.1016/j.jfma.2023.05.023372801382-s2.0-85161063414https://scholars.lib.ntu.edu.tw/handle/123456789/633261